GET THE APP

..

Molecular and Genetic Medicine

ISSN: 1747-0862

Open Access

Citations Report

Molecular and Genetic Medicine : Citations & Metrics Report

Articles published in Molecular and Genetic Medicine have been cited by esteemed scholars and scientists all around the world.

Molecular and Genetic Medicine has got h-index 29, which means every article in Molecular and Genetic Medicine has got 29 average citations.

Following are the list of articles that have cited the articles published in Molecular and Genetic Medicine.

  2022 2021 2020 2019 2018

Year wise published articles

61 59 33 62 69

Year wise citations received

348 369 376 335 318
Journal total citations count 3919
Journal impact factor 4.4
Journal 5 years impact factor 6.21
Journal cite score 6.74
Journal h-index 29
Journal h-index since 2018 19
Important citations

Ferrara F, Moles51 E, Böιcher‐Friebertshäuser E, Montomoli E, Cor54 D, Scoι S, Temperton N. The study of heterosubtypic an; body responses against Influenza A viruses elicited by seasonal vaccina; on using a pseudotype neutraliza; on assay.

Ferrara F, Moles41 E, BöRcher‐Friebertshäuser E, Cor43 D, CaRoli G, ScoR S, Temperton N. Haemagglu4nin ac4va4on by human transmembrane protease serine 2 or human airway trypsin‐like protease is necessary for produc4on of high 4tre influenza A virus pseudotypes for the evalua4on of pandemic poten4al.

Temperton NJ, Unit VP. Manuscript title.

Mather S, Scott S, Temperton N, Wright E, King B, Daly J. Author Proof.

Bentley E. The study of highly pathogenic emerging zoonotic virus envelope proteins through pseudotyped virus generation (Doctoral dissertation, University of Westminster).

Temperton N. The Viral Pseudotype Unit: viral pseudotype R&D, dissemination and education. Future Virology. 2016 Feb;11(2):113-6.

Ferrara F, Molesti E, Scott S, Cattoli G, Temperton N. The use of hyperimmune chicken reference sera is not appropriate for the validation of influenza pseudotype neutralization assays. Pathogens. 2017 Sep 25;6(4):45.

Molesti E, Temperton N. Influenza serological assays: from agar to plasmid-based approaches.

Wanner A. Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency. InAlpha-1 Antitrypsin 2016 (pp. 141-155). Humana Press, Cham.

Ferrara F, Moles E, Temperton N. Influenza, pseudotypes and pandemic preparedness.

Wallerström S, Lagerqvist N, Temperton NJ, Cassmer M, Moreno A, Karlsson M, Leijon M, Lundkvist Å, Falk K. Full text document.

Wallerström S. Serological and molecular methods for surveillance of influenza A virus. Inst för mikrobiologi, tumör-och cellbiologi/Dept of Microbiology, Tumor and Cell Biology; 2014 Nov 5.

Scott SD, Kinsley R, Temperton N, Daly JM. The optimisation of pseudotyped viruses for the characterisation of immune responses to equine influenza virus. Pathogens. 2016 Dec 15;5(4):68.

Li Q, Liu Q, Huang W, Li X, Wang Y. Current status on the development of pseudoviruses for enveloped viruses. Reviews in medical virology. 2018 Jan;28(1):e1963.

Yamamoto M, Matsuyama S, Li X, Takeda M, Kawaguchi Y, Inoue JI, Matsuda Z. Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome (MERS) corona virus S-mediated membrane fusion using the split protein-based cell-cell fusion assay. Antimicrobial agents and chemotherapy. 2016 Aug 22:AAC-01043.

King B, Temperton NJ, Grehan K, Scott SD, Wright E, Tarr AW, Daly JM. Technical considerations for the generation of novel pseudotyped viruses. Future Virology. 2016 Jan;11(1):47-59.

Ferrara F, Molesti E, Temperton N. The application of pseudotypes to influenza pandemic preparedness. Future Virology. 2015 Jun;10(6):731-49.

Mullin J, Ahmed MS, Sharma R, Upile N, Beer H, Achar P, Puksuriwong S, Ferrara F, Temperton N, McNamara P, Lambe T. Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by modified vaccinia Ankara-vectored influenza vaccines. Vaccine. 2016 Mar 29;34(14):1688-95.

Temperton NJ, Wright E, Scott SD. Retroviral Pseudotypes–from scientific tools to clinical utility. eLS. 2001 May 30:1-1.

Grehan K, Ferrara F, Temperton N. An optimised method for the production of MERS-CoV spike expressing viral pseudotypes. MethodsX. 2015 Jan 1;2:379-84.

Google Scholar citation report
Citations: 3919

Molecular and Genetic Medicine received 3919 citations as per Google Scholar report

Molecular and Genetic Medicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward